icad inc (ICAD) Peer Comparison

$3.87

$0.00 (0.00%)

As on 17-Jul-2025 09:30EDT

Market cap

$106 Mln

Revenue (TTM)

$20 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Edit

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Market cap ($ Mln)	106	64
Revenue ($ Mln)	20	80
Net Profit ($ Mln)	-5.23	-47.53
Net Margin (%)	-26.77	-59.45
RoE (%)	-17.38	--
Price to Earnings	--	--
Price-To-Book	3.45	6.45

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Operating Revenue	19.53	79.96
Cost of Revenue	2.82	30.59
Gross Profit	16.64	47.88
Operating Expenses	22.55	87.69
Operating Profit (EBIT)	-5.96	-38.56
Other Income	0.00	0.00
Profit before Tax	-5.13	-47.40
Provision for Tax	0.17	0.04
Profit after Tax (Net Income)	-5.23	-47.53
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Shareholder's Funds	30.79	-5.89
Minority Interest	0.00	0.00
Non-Current Liabilities	0.99	10.46
Current Liabilities	7.69	108.08
Total Liabilities	37.54	125.01

Assets ($ Mln)

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Non-Current Assets	11.35	46.44
Current Assets	28.12	66.21
Total Assets	37.54	125.01
Total Debt*	0.31	83.72
Net Current Assets	20.43	-41.87

Cashflow ($ Mln)

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Cash From Operating Activities	-3.95	-44.10
Cash Flow from Investing Activities	-0.52	-24.05
Cash from Financing Activities	0.00	-3.21
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	icad inc (ICAD)	Akoya BioSciences (AKYA)
ROCE (%)	-17.85	-47.89
ROE (%)	-17.38	-180.44
ROA (%)	-11.15	-23.26
EBIT Margin (%)	-27.74	-37.32
Net Margin (%)	-26.77	-59.45
Cash Profit Margin (%)	0.00	0.00

Growth Ratios

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Revenue Growth (%)	-0.53	-14.55
EBIT Growth (%)	-7.71	49.09
Net Profit Growth (%)	-75.17	30.10
EPS Growth (%)	-68.32	34.87
Book Value Growth (%)	-6.42	-117.82

Valuation Ratios

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Price / Earnings	-8.59	-2.05
Price / Book Value	1.68	14.94
Dividend Yield (%)	--	--
EV/EBITDA	-6.43	-4.38
Market Cap ($ Cr)	--	--

Solvency Ratios

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.01	-13.53
Current Ratio	3.66	0.61
Quick Ratio	3.57	0.40
Interest Coverage	-212.92	-3.60

Operating Efficiency Ratios

	icad inc (ICAD)	Akoya BioSciences (AKYA)
Debtors to sales (%)	33.94	14.68
Asset Turnover	0.42	0.39
Receivable days	126.66	68.81
Inventory Days	102.77	228.04
Payable days	111.98	110.97
Cash Conversion Cycle	117.44	185.88

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly